Wednesday, June 29, 2016

Not quite right

A story in Wednesday's paper about the bladder cancer treatment Tecentriq should have noted that Dr. Daniel Petrylak was a lead investigator in phase two trials of the drug as well as phase one trials


Post a Comment

Subscribe to Post Comments [Atom]

<< Home